Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06546943 · ClinicalTrials.gov registry record
Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations
A clinical trial of Cystic Fibrosis Pulmonary Exacerbation, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06546943 is a study of Cystic Fibrosis Pulmonary Exacerbation that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06546943, a study of Cystic Fibrosis Pulmonary Exacerbation, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cystic fibrosis (CF).
Conditions Studied
Study Locations (1)
Colorado
- Children's Hospital Colorado, University of Colorado Denver - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-02-04 |
| Est. Completion | 2025-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06546943
The ClinicalTrials.gov registry entry for NCT06546943 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cystic Fibrosis Pulmonary Exacerbation appearing as the primary indexed condition, and to 0 interventions.
NCT06546943 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT06546943 about?
NCT06546943 is a clinical study titled "Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations". The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cystic fibrosis (CF).
What is the current status of trial NCT06546943?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-02-04. Estimated completion is 2025-10-31.
What conditions does trial NCT06546943 study?
This clinical trial studies the following conditions: Cystic Fibrosis Pulmonary Exacerbation.
Who is sponsoring clinical trial NCT06546943?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06546943 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis Pulmonary Exacerbation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.